Bevacizumab Treatment For Type 1 ROP

Clinical trial NCT04634578 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04634578
Sponsor: Jaeb Center for Health Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Retinopathy of Prematurity

Start date: 2022-05-01
Primary completion: 2025-07-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.